Board composition through the scale phase.

The principle

A board exists to protect the company’s interests across stakeholders, hire and oversee the CEO, and provide accountability on capital allocation. It does not exist to manage the company. The most common failure mode in scaleup boards is governance creep - directors who treat board meetings as operating reviews, demanding granular reporting on commercial decisions that should sit with the executive team. The fix is structural: clear lines between board-level decisions (capital allocation, M&A, executive comp, exit) and operating decisions (hiring, pricing, product roadmap, marketing budget). Term sheets that blur this line eventually slow the company.

Composition by stage

Pre-Series A (€0.5M–€1.5M ARR)

Three directors: two founder seats, one lead-investor seat. One or two observer seats for additional investors. The founder block holds a clear majority. Independent directors at this stage are rarely worth the cost and overhead - the founder’s time is better spent operating, and independents at this stage typically do not have the operating insight to add disproportionate value. If an independent is added, it should be sector-specific: someone who has scaled a similar company through the next stage.

Series A to mid-scale (€1M–€5M ARR)

Three or five directors. The five-director version: two founder seats, two investor seats (lead + co-lead or lead + Series A holder), one independent. The investor seats now match the founder block in voting weight, but the independent is selected by the founder with investor consent - a sector-experienced operator chosen for execution insight, not for board management. Two observer seats remain available for non-lead investors. Director compensation introduced at this stage (typically €15K–€40K per year for active independents).

Series B and beyond (€5M+ ARR)

Five or seven directors. The seven-director version: two founder seats (or one if a CEO has been hired separately), three investor seats representing the major holders, two independents - typically one operator-experienced and one finance/audit-experienced as the company prepares for exit infrastructure. Audit and compensation committees formalise. Quarterly cadence becomes mandatory; annual strategy off-sites are typical. Director compensation rises (€40K–€80K for active independents in Europe; higher in US).

Investor seats and observer rights

Investor directors carry fiduciary duty to the company, not to the fund that appointed them. This matters: a TGC director on a portfolio board, asked to choose between a higher-priced acquisition that maximises fund returns and a lower-priced acquisition that better preserves founder optionality, must analyse the decision against the company’s interests, not the fund’s. Founders should hold their investor directors to that standard explicitly. The structural difference between operator-led and capital-only board behaviour is covered in operator-led vs traditional investors.

Observer rights are weaker: the holder attends meetings, gets the board pack, but does not vote and has no fiduciary duty. This is often the right structure for minority growth-equity investors who do not warrant a full director seat. Observer behaviour matters: a constructive observer who flags risks early adds disproportionate value; an observer who treats meetings as performance reviews or proxy voting forums damages the board cadence and should be moved to written reporting only.

Protective consents

Protective consents are the contractual mechanism by which a minority investor exercises veto over specific decisions. The reasonable scope is narrow:

• M&A above defined thresholds. Typically transactions above 50% of company value or change of control.
• Share issuance dilutive of the lead. Senior preferred shares, new option pools above stated caps, or rounds priced below the last round.
• Indebtedness above thresholds. Typically debt facilities above 1× ARR or 3× EBITDA, depending on the company’s capital structure.
• Senior compensation above defined bands. CEO, CTO, CRO, CFO comp above pre-agreed market bands.
• Amendments to the constitutional documents. Articles of association, shareholder agreement, anti-dilution mechanics.

Protective consents on routine hiring, marketing budgets, product roadmap, vendor selection, or operating-level decisions are over-reach. Founders should reject these in negotiation; investors who demand them are signalling a control-orientation that is incompatible with minority investing.

Board-meeting cadence

Quarterly formal meetings, with the board pack distributed five business days ahead. Pack contents: financial statements with KPI dashboard, written CEO update covering progress against operating thesis, hiring report, runway and capital plan, and 2–3 strategic discussion items pre-flagged by the CEO. Meeting time is allocated 60% to discussion items and 40% to standing reports.

Between board meetings, monthly operating reviews led by the founder with the relevant lead-investor partner. These are operating, not governance - they exist to surface execution risks early so the board does not learn of issues at the quarterly meeting. TGC’s cadence is heavier here than typical capital-only growth equity because the investment is tied to embedded operating capacity; the partner needs to know the operating state in real time, not quarterly.

Founder-friendly conventions

The clean version of a Series A or growth-equity term sheet for B2B SaaS at €1M–€5M ARR:

• 1× non-participating preferred - preference recovery or pro-rata equity participation, not both.
• Broad-based weighted-average anti-dilution - not full-ratchet.
• Board composition proportionate to ownership - no designated protective directors that out-vote the economic stake.
• Standard minority-protective consents only - the five categories listed above; nothing further.
• Vesting on founder shares - typically 4-year monthly vest with a 1-year cliff, with acceleration on change of control.
• Information rights - quarterly financials, annual audited accounts, monthly KPI report. No on-demand audit rights.
• Tag-along + drag-along - standard mechanics that protect minority investors in M&A while preserving founder consent at thresholds.

How TGC operates board roles

TGC takes one director seat in portfolio companies where ownership warrants it; observer rights otherwise. The TGC partner attending the board (regional partner per geography) operates against the firm’s explicit cadence: monthly operating review, quarterly board, written quarterly memo from the founder. The director’s value-add is sector-specific - TGC partners come from operating roles in B2B SaaS - and the embedded-team relationship is held separately from the governance relationship so day-to-day operational support does not bleed into board-level escalation.

Frequently asked questions

How big should a B2B SaaS scaleup's board be?

At Series A and below, 3 directors (2 founder, 1 lead investor) plus 1–2 observers. At Series B (€5M+ ARR), 5 directors (2 founder, 2 investor, 1 independent) plus 2 observers. Adding more directors at €1–5M ARR rarely improves decision quality and frequently slows it.

What does TGC ask for at board level?

One investor director seat proportionate to ownership when the cap-table position warrants it. Standard minority-protective consents (M&A, change of control, share issuance dilutive of the lead, senior compensation above defined thresholds, indebtedness above thresholds). No supermajority blockers on operating decisions; no protective directors that out-vote economic stakes.

When should a B2B SaaS founder add an independent director?

Once the company has crossed €5M ARR or is one quarter from doing so. Earlier, the founder's time is better spent operating; an independent at €1M ARR rarely earns their fee. The right independent is sector-specific (someone who has scaled a similar company through the next stage), not a general-purpose advisor.

What is the difference between a director and an observer?

A director has a fiduciary duty to the company, votes on board resolutions, and signs off on accounts and major decisions. An observer attends meetings without voting rights, gets the board pack, and has no fiduciary duty. Investors at minority stakes often take observer rights rather than directorships to limit governance overhead while maintaining visibility.

Can a founder lose control through bad board composition?

Yes. Two patterns to avoid: (1) supermajority consents that let a single investor block routine operating decisions, (2) board composition where investor directors plus independents (chosen by investors) outnumber the founder. Even with a minority equity stake, a misconstructed board grants effective control to the investor block.

How does TGC structure board interactions for portfolio companies?

Quarterly formal board meetings with a written pack 5 business days ahead, monthly operating reviews between board cycles led by the founder with the relevant TGC partner, and a quarterly written board memo from the founder summarising progress, risks, and asks. The cadence is heavier than capital-only growth equity because TGC is operationally accountable for execution outcomes alongside capital.

What protective consents are reasonable for a minority growth-equity investor?

M&A above thresholds, change of control, share issuance dilutive of the lead, indebtedness above thresholds (typically 1× ARR), senior-comp above thresholds (typically a defined band per role), and amendments to the company's constitutional documents. Protective consents on routine hiring, marketing budgets, or product roadmap are over-reach and should be rejected.

Speak with a partner Governance platform

Related reading: Operator-led growth equity, explained · SaaS PE earnout structures · TGC vs Private Equity